GLAXOSMITHKLINE INTERNATIONAL LIMITED

Active London

Other business support service activities n.e.c.

0 employees website.com
Other business support service activities n.e.c.
G

GLAXOSMITHKLINE INTERNATIONAL LIMITED

Other business support service activities n.e.c.

Founded 21 Sept 1988 Active London, United Kingdom 0 employees website.com
Other business support service activities n.e.c.

Previous Company Names

SMITHKLINE BEECHAM INTERNATIONAL LIMITED 6 Sept 1989 — 27 Oct 2004
SMITHKLINE BECKMAN INTERNATIONAL LIMITED 21 Oct 1988 — 6 Sept 1989
Accounts Submitted 29 May 2025 Next due 30 Sept 2026 4 months remaining
Confirmation Submitted 8 Sept 2025 Next due 22 Sept 2026 3 months remaining
Net assets £1,577M £47M 2024 year on year
Total assets £1,805M £68M 2024 year on year
Total Liabilities £228M £21M 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

79 New Oxford Street London WC1A 1DG United Kingdom

Full company profile for GLAXOSMITHKLINE INTERNATIONAL LIMITED (02298366), an active company based in London, United Kingdom. Incorporated 21 Sept 1988. Other business support service activities n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type audit-exemption-subsidiary
Next accounts 31 Dec 2025
Due by 30 Sept 2026 4 months remaining

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

N/A

Net Assets

£1577.00M

Increased by £46.81M (+3%)

Total Liabilities

£227.79M

Increased by £21.39M (+10%)

Turnover

N/A

Employees

N/A

Debt Ratio

13%

Increased by 1 (+8%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (1)

Glaxosmithkline Biologicals
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Setfirst Limited

United Kingdom

Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

GSK PLC united kingdom
SETFIRST LIMITED united kingdom
GLAXOSMITHKLINE INTERNATIONAL LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
8 Sept 2025Confirmation StatementConfirmation statement made on 8 Sept 2025 with no updates
29 May 2025OtherNotice of agreement to exemption from audit of accounts for period ending 31/12/24
29 May 2025OtherAudit exemption statement of guarantee by parent company for period ending 31/12/24
29 May 2025AccountsAnnual accounts filed
29 May 2025AccountsAnnual accounts made up to 31 Dec 2024
8 Sept 2025 Confirmation Statement

Confirmation statement made on 8 Sept 2025 with no updates

29 May 2025 Other

Notice of agreement to exemption from audit of accounts for period ending 31/12/24

29 May 2025 Other

Audit exemption statement of guarantee by parent company for period ending 31/12/24

29 May 2025 Accounts

Annual accounts filed

29 May 2025 Accounts

Annual accounts made up to 31 Dec 2024

Recent Activity

Latest Activity

Confirmation statement made on 8 Sept 2025 with no updates

8 months ago on 8 Sept 2025

Notice of agreement to exemption from audit of accounts for period ending 31/12/24

12 months ago on 29 May 2025

Audit exemption statement of guarantee by parent company for period ending 31/12/24

12 months ago on 29 May 2025

Annual accounts filed

12 months ago on 29 May 2025

Annual accounts made up to 31 Dec 2024

12 months ago on 29 May 2025